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The general trend in biomaterials is to use and employ materials that play an active ro le in tissue 
regeneration rather than passive and inert materials.  Therefore, understanding how a material 
interacts with the surrounding environments, including cells and tissue fluid, allows material 
design to be tailored so that implants can be constructed to promote a specific biological response, 10 
helping them better perform their function.  This class of materials has been described as the 
“Third Generation” of biomaterials.  Phosphate based glasses fall into this category and it has been 
shown that the properties of these glasses can be tuned via their composition according to the 
desired end application.  These glasses can be prepared as melt quenched or sol -gel bulk form 
suitable for potential hard tissue engineering applications and as vehicles for  antimicrobial agents.  15 
They can also be prepared as fibres suitable for soft tissue engineering applications such as those 
involving muscle, ligaments, and tendon, where, like the fibres, the tissue has a high degree of 
anisotropy. 
1. Introduction 
Recently, interest in soft and hard tissue engineering for 20 
improved tissue regeneration has fuelled the need for novel 
biodegradable materials having a specific and controllable 
bioactivity [1].  Bioactive glasses, silicate based in particular, 
have been the subject of intense interest for the last three 
decades as materials for tissue regeneration applications.  In 25 
vivo, when they exposed to physiological fluids, they form a 
surface apatite layer; this layer has the capacity to bond to 
collagen synthesised by connective tissue cells such as 
osteoblasts [2].  One commercially available bioactive glass is 
Bioglass® which has a  composition  known as 45S5 30 
corresponding to 45.0 wt% SiO2, 24.5 wt% CaO, 24.5 wt% 
Na2O and 6.0 wt% P2O5 [3-5].  Today, the 45S5 composition 
is used as a benchmark by which the performance of new 
silicate based bioactive glasses is measured.  Such glasses 
have shown great success in many clinical applications 35 
especially in dental and orthopaedic fields. However, there are 
questions raised related to the long term effect of silica [6] 
and the slow degradation of these glasses, often taking 1 to 2 
years to disappear from the body [7, 8].  Because of these 
limitations, the search for new materials for the repair of bone 40 
defects has continued and has led to the emergence of 
phosphate based glasses as potential alternatives. 
 Phosphate based glasses in the CaO-Na2O-P2O5 system 
have unique dissolution properties in aqueous based fluids.  
Degradation rates can be varied from hours to several weeks 45 
by changing the glass composition.  Moreover, all the 
constituents of these glasses are elements naturally inside the 
body and therefore can be excreted by the normal 
physiological processes.  Furthermore, these glasses can be 
synthesised to include dopants that are able to induce a 50 
specific biological function and enhance biocompatibility [9-
12]. 
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Figure 1: Silicate (a) and phosphate (b) tetrahedra. 
This review starts with a general description of phosphate 
glasses, highlighting their differences with their silicate based 
counterparts and explores what these glasses can offer in 
terms of biomedical applications.  Particular focus is placed 60 
on phosphate glass chemistry, terminology and structure.  
Next we discuss the processing techniques used to prepare 
these glasses. In the case of the melt-quenched prepared 
glasses, both monoliths and glass fibres are described. Recent 
developments in using sol-gel methods to prepare phosphate 65 
glasses for biomedical applications are reviewed.  The article 
concludes with a discussion of the future of phosphate based 
glasses as biomaterials and highlights possible avenues of 
potential application.  
2. Comparison of Phosphate and Silicate Based 70 
Glasses 
Silica (SiO2) is a classic network forming oxide.  It is 
common in nature in both crystalline and glassy forms 
because of the strong affinity of silicon towards oxygen, and 
the natural abundance of these two elements.  The basic unit 75 
of the silicate based glasses is the SiO4 tetrahedron shown in 
Figure (1a).  This unit can share up to four oxygen atoms with 
other such tetrahedral units to form a 3D network structure.  
 Phosphorus also has an affinity towards oxygen and as a 
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consequence phosphates are common in nature. In common 
with silicate based glasses, the building block of phosphate 
glasses is a tetrahedral unit. However, as can be seen in Figure 
1, the PO4 unit is quite different from the SiO4 unit.  This is 
because phosphorus nominally has a charge of 5+ whereas 5 
silicon has a charge of 4+.  Therefore when SiO4 tetrahedra 
form a network they can share all four of their oxygen atoms 
to give the stoichiometry SiO4/2 or SiO2 which is charge 
balanced (assuming a charge of 2- on the oxygen).  In 
contrast, when forming an analogous charge balanced 3D 10 
binary oxide, phosphorus can only share three out of its four 
oxygens which gives the stoichiometry of PO (1+3/2) or P2O5.  
In the case of the P2O5, the oxygen atoms that are not shared 
between phosphate tetrahedral share their two unpaired 
electrons with the P5+ ions to form a terminal double bond 15 
(Figure 1b) [13].  
 The fact that phosphate anions contain at least one terminal 
oxygen limits the connectivity of phosphate based glasses 
relative to their silicate based counterparts.  Therefore, in 
general the rigidity, which is related to the interatomic forces, 20 
is less in phosphate glasses compared to silicate glasses. 
Moreover, when mixed with metal oxides, phosphate glasses 
contains fewer cross-links but a higher number of terminal 
oxygen atoms than silica glasses of the same metal oxide 
content.  These two structural properties result in more 25 
flexibility in the orientation of PO4 tetrahedra [13].  
Therefore, the range of glass formation in binary phosphate 
glass in systems is wider than in the analogous silicate based 
system, even in the presence of alkali or alkali earths. 
 Pure vitreous silica is thermally and chemically stable.  The 30 
addition of modifying oxides such as Na2O, K2O, MgO, and 
CaO, which are not part of the glass network and disrupt it 
resulting in terminal Si–O bonds, produces less stable glasses 
[14-15]. Pure vitreous phosphorus pentoxide (P2O5), on the 
other hand, is chemically unstable with regard to hydrolysis of 35 
the P–O–P bonding by atmospheric moisture; in this case the 
addition of metal oxides improves its stability because P–O-
Mn+ (where M = metal cation) bonds are generally more 
stable towards atmospheric hydrolysis [16]. 
 From a technical standpoint of pure melt quenched, 40 
vitreous silica is only used in very specialized applications 
due to the very high melting temperatures involved in its 
manufacture.  The addition of modifying oxides which reduce 
network connectivity significantly reduce the melting 
temperature required.  Phosphate based glasses, however, can 45 
be prepared at relatively low temperatures [6]. 
 These two types of glass also differ in their aqueous 
dissolution mechanisms and in the stability of resultant 
anionic species.  Dissolved silicate species can easily be 
polymerised or repolymerised to form species with no 50 
resemblance to the original glass structure, whereas phosphate 
chains and rings are quite stable in aqueous solution [17]. 
 Due to their high melting temperatures, silica based 
bioactive glasses are difficult to draw into fibers and the 
addition of metal oxides such as Na2O and CaO to lower the 55 
melting temperature can adversely affect the glass bioactivity 
by increasing its tendency towards crystallization.   The of use 
sol-gel chemistry to overcome the problems of fiber drawing 
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Figure 2: Nomenclature and representation of PO4 tetrahedra 65 
with different polymerizations [22]. 
is still in its infancy [18].  In contrast, phosphate glasses 
containing more than 45 mol % P2O5 can easily be drawn into 
fibers [10].  From a structural viewpoint, the fibre drawing 
ability or spinnability is related to the ability of the longer 70 
phosphate chains to entangle with other chains.  Such 
interactions allow continuous filaments to be formed instead 
of clusters or droplets.  Milberg and Daly [19] proposed that 
in perfectly oriented fibres, all chain axes are parallel to the 
fibre axis, and the rotational disorder of the chains around 75 
their own axes corresponds to the cylindrical symmetry of the 
fibre. Moreover, Murgatroyd [20] suggested that the drawing 
operation preferentially selects the strong P-O-P bonds and 
the continuity of fibres is related to the ability of these bonds 
to be aligned along the long axis of the fibre.  Whereas, weak 80 
P-O-P bonds can be extended for a short distance along the 
strong bonds, but are not able to form continuous fibres [20].  
 Compared to silicate glasses, phosphate glasses have poor 
chemical durability and the poor durability limits their use in 
technological applications.  However, phosphate glasses are 85 
preferred in other applications such as release of oligo-
elements in soils.  Moreover the solubility of phosphate 
species in Bioglass is responsible for the nucleation and 
apatite layer formation that is considered to be the main factor 
responsible for the bioactivity of Bioglass [21]. 90 
3. Terminology and Chemistry of Phosphate-
Based Glasses 
As discussed in the previous section, the PO4
3- tetrahedron is 
the basic building block of structure the phosphate based 
glasses.  Phosphate tetrahedra are classified by the number of 95 
oxygen atoms they share with other phosphate tetrahedra.  An 
oxygen atom shared in this way is usually referred to as 
bridging oxygen, abbreviated to BO hereafter.   The various 
types of phosphate tetrahedra that result from this 
classification are labeled using Q i, where i refers to the 100 
number of BOs and ranges from 0 to 3.  For example, Q3 PO43- 
tetrahedra share three covalently bonded BOs with 
neighbouring PO43-tetrahedra as found in vitreous P2O5.  In 
terms of the structure of the phosphate network, Q3 moieties 
are known as a branching units and since they have a O/P 105 
ratio of 2.5 (i.e. PO(1+3/2)) they have neutral charge.  Q
2 
tetrahedra possess two BOs which results in an O/P ratio of 3 
and a net charge of 1-. Structurally, Q2 units can be 
considered as PO3
- middle groups in phosphate chains.  Q2 
tetrahedra have one BO and hence an O/P ratio of 3.5 and a 110 
net charge of 2-.  Structurally Q1 units can be considered as 
representing P2O7
4- dimmers or as terminating groups at the 
end of phosphate chains.  Q0 represents an isolated (PO4)
3-
tetrahedron (i.e. O/P = 4) with no BOs to neighbouring 
tetrahedra; (PO4)
3- groups are also known as orthophosphate 115 
 units [22-24]. The various Q species discussed above are 
illustrated in Figure 2. 
 The structure of vitreous P2O5 consists of only Q
3  
phosphate tetrahedra that form a three dimensional network; 
the addition of modifying metal oxides, however, results in 5 
the “depolymerisation” of this network via the cleavage of P -
O-P bonds with the creation of negatively charged NBOs at 
the expense of BOs.  The negatively charged NBOs charge 
balance the metal cations and coordinate them such that they 
achieve their preferred coordination number [13, 23, 25, 26].  10 
The depolymerisation model proposed by Kirkpatrick and 
Brow [23] predicts that the dominant Qi species changes 
according to Q3 → Q2 → Q1 → Q0 as the amount of 
modifying oxide increases.  Increasing the amount of metal 
oxide results in an increase in the overall O/P ratio and this 15 
determines the average number of BO per phosphate 
tetrahedron; from this one can predict the dominant Qi 
species.  
3.1. Ultraphosphate Glass Structure  
Ultraphosphate glasses are those with compositions in the 20 
range (M2/vO)x(P2O5)1-x, where 0 ≤ x ≤ 0.5 and v is the 
valance of the metal cation.  The ultraphosphate composition 
can also be described in terms of the atomic ratio of oxygen 
phosphorus, i.e. 3.0 ≤O/P ≤ 2.5.  Glasses with compositions in 
this range are expected to have network structures dominated 25 
by Q2 and Q3 species.  Structural studies using 31P NMR have 
confirmed this to be the case and verified that the 
concentrations of Q2 and Q3 groups can be calculated from 
Van Wazer‟s chemically simple depolymerisation model [27].  
The Q2 and Q3 tetrahedra appear to be randomly linked, at 30 
least in alkali ultraphosphate glasses.  In glasses with a high 
P2O5 concentration (greater than 75-80 mol%), the phosphate 
network resembles that of vitreous P2O5. With increasing 
modifier content, there is a loss of the extended-range order 
associated with vitreous P2O5, as the concentration of Q
2 35 
species.  The composition at which this transition occurs 
depends on the preferred coordination number and valence of 
the modifying cation since it relates to the relative 
concentrations of NBOs and cations.  Hoppe [13] has 
postulated that at low cation concentrations, both NBOs of the 40 
Q2 units coordinate to the same cation; whereas at higher 
cation concentrations, each NBO can coordinate a separate 
cation resulting in a structural relaxation. 
3.2. Metaphosphate Glass Structure  
Metaphosphate glass have the composition 45 
(M2/vO)0.5(P2O5)0.5 and an O/P ratio of 3.  Their structures 
consist of infinitely long chains and/or rings of Q2 units [24].  
These phosphate chains are linked through bonds between the 
terminal NBOs and the modifying cations.  Structural studies 
have revealed that the properties of metaphosphate glasses are 50 
less dependant on the nature of the P O P that form the 
chains than on the P O Me bonding between chains.  In 
general, as the field strength of the modifying cation 
increases, there is an increase in the rigidity of the 
metaphosphate network and an associated increase in glass 55 
transition temperature [23]. 
3.3. Polyphosphate Glass Structure  
 Polyphosphate glasses have a composition compositions in 
the range (M2/vO)x(P2O5)1-x, where x > 0.5, and an O/P >3. 
The structure of polyphosphate glasses is based on Q2 chains 60 
terminated by Q1 units.  At the pyrophosphate composition (x 
= 0.667), the structure is dominated by phosphate dimers, i.e. 
two Q1 units sharing a bridging oxygen atom. At x = 0.75, 
only isolated orthophosphate Q0 units are present [24].  
Polyphosphate glasses are often more durable than their 65 
metaphosphate counterparts due to the reduction of the more 
readily hydrolyzed Q2 units in the structure [23]. 
4. Melt Quenched Phosphate Based Bulk Glasses 
Most phosphate based glasses are prepared by melt-quenching 
methods. A mixture of oxide precursors is melted in a furnace 70 
at temperatures of over 1000°C; the exact temperature used 
depends on the final composition of the glass.  Once a 
homogeneous melt has been achieved, the glass is formed by 
casting different shapes such as rods and plates.  To remove 
residual stress, the melts are normally cooled quickly through 75 
the glass transition temperature (Tg) and then the cooled very 
slowly to room temperature in an annealing step. 
4.1. Technological Applications 
Phosphate based glasses have been used in a wide range of 
technological applications such as sensors, solid-state 80 
batteries, laser devices, and air tight seals for metals with a 
high coefficient of thermal expansion [28].  Phosphate glasses 
have also been developed for achromatic optical elements due 
to their low dispersion and relatively high refractive indices.  
Iron-containing phosphate glasses have found uses as matrices 85 
for vitrifying nuclear waste products [29-31].  Their capacity 
for high waste loading, low processing temperature and high 
chemical durability offer significant advantages compared to 
most silicate and borosilicate glasses.  They are reported to 
maintain their high chemical durability even after 90 
devitrification of waste forms [32]. 
4.2. Medical Applications 
4.2.1Controlled Release Glasses (CRG) 
Controlled release glasses are a class of materials that 
completely dissolve in aqueous media leaving no solid 95 
residues.  Their degradation is an erosion controlled process 
that follows zero order release over the life of the material, 
i.e. the release rate is constant and independent of time and 
concentration [33].  They can be produced in different forms 
such as powder, granules, fibre, cloth, tubes, and monoliths of 100 
various shapes [34].  These glasses have been under 
development in the Standard Telecomminucation Laboratories 
since the early 1970s [35].  They find application in many 
different areas such as feeding of bacteria, controlling parasite 
infection in water canals, veterinary use or even treatment of 105 
infections in humans. Some examples of these uses are 
described below. 
 Polyphosphate glass provides a source of phosphate ions 
that can support the growth of recombinant Escherichia Coli 
to a density 40 % higher than that obtained with typical 110 
 fermentation media. The high solubility of polyphosphates 
together with the absence of precipitate formation when mixed 
with the fermentation media are key benefits for such 
applications [36].  
 Soluble phosphate glasses containing such as copper, 5 
cobalt, and selenium, designed for oral administration in form 
of a rumen bolus to ruminant animals for the treatment of 
trace element deficiencies, are manufactured under the trade 
name of Cosecure® [37-40]. 
 Copper releasing phosphate glasses have been used as 10 
molluscicides to control the snail hosts of schistosomiasis.  
Glass composition and physical form can be tailored in a 
reproducible manner to suit the chemistry of the water body 
being treated. Moreover, most of the released Cu is in non-
toxic or weakly toxic forms such as copper polyphosphate 15 
complexes which acts as secondary releasing agents [38-40]. 
Silver releasing phosphate glasses are used clinically to 
combat long term infection in indwelling catheters. A 
cartridge with silver containing glass is inserted in line 
between the catheter and urine collection bag. This cartridge 20 
treats the urine as it flows through it from the bladder to the 
collection bag. The silver ions released are found to inhibit 
bacterial proliferation [34] and have the potential to be used in 
the treatment of vesicoureteral flux and urinary incontinence 
[41]. 25 
4.2. 2. Hard Tissue Engineering Applications 
Biodegradable scaffolds, which are eventually replaced by the 
natural tissue, are desirable constructs for tissue engineering 
applications. CaO-Na2O-P2O5 glasses have properties that 
lend them to use as hard tissue substitutes or as substrates for 30 
synthetic orthopaedic graft materials.  Compositionally they 
are similar to the inorganic component of bone [42].  
Furthermore, fluoride-doped phosphate glasses have been 
developed that play an active role in stabilising the apatite 
layer [42]. Phosphate glasses can also be doped with a variety 35 
of metal oxides to modify their physical properties [43, 44].  
It is reported that the ionic environment caused by the 
leaching of ions from these glasses during their degradation 
has an impact on the biological response of cells [45]. For 
example, Ca2+ ions have been implicated in stimulating 40 
osteoblast-like cell proliferation and differentiation and 
phosphate ions act as extracellular „pool‟ responsible for the 
release of Cbfa-1, an important bone marker, from bone cells 
[45]. 
 For hard tissue engineering applications, a number of glass 45 
systems have been developed by additions of various metal 
oxides such as Fe2O3, Al2O3, ZnO, and TiO2 into the parent 
glass. Comprehensive studies have been reported that give an 
overview of the correlation between the basic glass structure 
and the biocompatibility. 50 
4.2.2.1. Binary System (s) 
Binary sodium phosphate glasses (Na2PO4H-NaPO4H2), 
developed by Gough et al. [46, 47], demonstrated a minimal 
level of macrophage activation evident from low amounts of 
peroxide and interleukin-1β release.  Moreover, early primary 55 
craniofacial osteoblast attachment and spreading was also 
observed on those glasses.  Upon long term culture (28 days), 
the craniofacial osteoblasts exhibited cytoskeletal 
characteristics and a level of collagen synthesis similar to 
those of the positive control.  The biocompatibility of these 60 
glasses was related to their degradation and the ions released.  
However, it was difficult for cells to attach to such highly 
soluble glasses because the labile surface prevented the 
formation of a physical anchorage.  
4.2.2.2. Ternary System (s) 65 
Uo et al. [48] developed the P2O5-CaO-Na2O ternary glass 
system and assessed the cytocompatibility by direct contact 
cytotoxicity assay using dental pulp cells.  Their study 
reported that the samples containing 50 mol% P2O5 were not 
very cytotoxic.  The cytotoxicity was found to decrease with 70 
increasing P2O5 content due to a change in pH from neutral at 
50 mol % to acidic at 60 mol% or more.  Thus, the authors 
related the cytotoxicity to the glass degradation, the 
associated pH changes and ionic concentration in the media. 
 Franks et al. [49] studied the same ternary glass system in 75 
the composition range (P2O5)45(CaO)x(Na2O)55-x, where x 
was between 8 and 40 mol %. Initial work focused on the 
degradation and ion release of these glasses; the results 
suggested that the interaction of the Ca2+ ions with the glass 
network controlled glass degradation, and an inverse 80 
relationship existed between calcium oxide content and the 
degradation rate. The biological response of this glass system 
was tested by Salih et al. [6] to assess their suitability for 
potential bone regeneration applications. Two human 
osteoblast cell lines, MG63 and HOS (TE85) were incubated 85 
in the glass extracts with different concentrations (neat, 1:4, 
1:16, 1:64 dilution) for two and five days. MTT assay was 
used to study cell growth, and ELISA was used to measure the 
expression of antigens such as bone sialoprotein, osteonectin, 
and fibronectin which play a vital role in bone metabolism 90 
and integrity. The results showed that the glasses with lower 
solubility enhanced bone cell growth and antigen expression 
at all tested dilutions.  The highly soluble glasses, however, 
significantly reduced cell proliferation, and down-regulated 
antigen expression especially with neat and 1:4 dilutions at 95 
five days. The authors suggested that these results were 
related to ions released from the glass during degradation and 
the resultant pH changes. They also suggested that with less 
soluble glasses, greater amounts of Ca2+ ions are released, 
which is known to have an essential role in cell activation 100 
mechanisms affecting both cell growth and function.  
However, with highly soluble glasses, a sharp increase in pH 
associated with high release rates of Na+ and phosphate ions 
(PO4
3-) may have a deleterious effect on cells. 
 Due to the high degradation rate and unfavorable cellular 105 
response associated with high sodium content glasses, Franks 
studied the effect of replacing the Na2O with K2O [42]. For 
this new study, glasses of composition 
(P2O5)45(CaO)x(K2O)55-x, where x is between 16 and 32 mol 
% were used. Glass with CaO content outside this range was 110 
difficult to prepare due to its crystallisation upon casting.  It 
was observed that the P2O5-CaO-K2O system dissolved at a 
higher rate than the analogous P2O5-CaO-Na2O system and 
hence no biocompatibility study was conducted on this glass 
system. 115 
 Bitar et al. [50] investigated the short-term response on 
 exposure to phosphate based glass of two typical cellular 
components of a hard/soft tissue interface, periodontal 
ligament/mandible and patellar tendon/tibia.  Human oral 
osteoblasts, oral fibroblasts and hand flexor tendon fibroblasts 
were co-cultured on glasses with different degradation rates 5 
((P2O5)45(CaO)x(Na2O)55-x where x = 30-48).  Quantitative 
and morphological assessment of cell adhesion and 
proliferation for all cell types was recorded.  Immunolabelling 
was also used to establish phenotypying of both osteoblasts 
and fibroblasts.  The results showed that glass discs with less 10 
than 40 mol% CaO support little or no cell adhesion and 
survival.  This behaviour was related to the high solubility of 
the surface layer of these glasses; therefore, it is difficult for 
cells to attach to a labile surface and to form a physical 
anchorage as observed by Gough et al., [46, 47].  The authors 15 
concluded that ternary glass compositions with high CaO 
content (46 and 48 mol%) support high numbers of adherent 
and viable cells as indicated by DNA content, and also 
maintain cellular function as indicated by phenotypic gene 
expression up to 7 days. 20 
 From these studies, it is clear that the glass degradation, 
and the associated ion release, and pH change of the 
surrounding environments, are factors affecting 
biocompatibility.  Therefore, additions of metal oxides known 
to affect the chemical durability of phosphate glass to the 25 
P2O5-CaO-Na2O system are expected to have an effect on 
biocompatibility.   The quaternary systems that result from 
such additions are discussed in the next section. 
4.2.2.3. Quaternary Systems/Dopants  
Knowles et al., [51] synthesized quaternary glasses of 30 
composition (P2O5)45(CaO)x(Na2O)55-x-y(K2O)y, where y = 
20, 24, 28 or 32 and x = 0-25, in order to study the affect of 
substituting Na+ ions with larger K+ ions.  The aqueous 
degradation of this system was affected by both CaO and K2O 
content.  An anomaly in degradation was observed at high 35 
CaO content, where weight gain was observed prior to weight 
loss.  The MTT assay showed that the K+ had a positive effect 
on cell proliferation only at high content, 20 mol % K2O, 
regardless of the associated increase in degradation. 
 In order to understand the effect of changing the radius of 40 
the divalent cation in a quaternary system, Franks et al. [52] 
substituted Ca2+ ions with smaller Mg2+ ions in 
(P2O5)45(CaO)32-x(Na2O)23(MgO)x, where x = 0-22, 
glasses.  This study concentrated on the overall degradation 
characteristics of the glasses and the effect of released ions on 45 
cell proliferation.  The results showed that degradation of the 
glass as a function of time changed from exponential to linear 
with decreasing CaO content.  This emphasised the influential 
role of CaO on the degradation process. The degradation rate 
was decreased by substitution of CaO with MgO despite Mg2+ 50 
having the same valence as Ca2+.  The MTT assay was used to 
assess the effect of different dilutions of glass extracts on the 
proliferation of human osteoblasts (MG63) for two and five 
days.  The results were normalised to the control cells 
incubated in normal medium.  The result showed that glasses 55 
with little or no MgO showed a slight decrease in cell 
proliferation only after two days; however, after five days all 
glass compositions tested showed equal or greater cell 
proliferation than the control. 
 Salih et al. [53] added zinc oxide to PBG with the aim of 60 
promoting osteoblast cell adhesion and improving the 
potential for use in bone tissue engineering applications.  The 
compositions investigated were (P2O5)50(CaO)40-
x(Na2O)10(ZnO)x, where x = 0-20. Attachment of osteoblast-
like cells was assessed morphologically by scanning electron 65 
microscopy and the effect of the glass extract (neat and 10% 
diluted) on cell proliferation over periods of up to 7 days was 
determined by cyquant assay.  The results showed that after 
24 hours of culture, the cells attached to all glass 
compositions but still maintained round morphology 70 
suggesting lack of spreading on the glass surfaces.  Moreover, 
cell proliferation increased with increasing ZnO content up to 
5 mol%, but never reached levels exhibited by cells grown on 
the positive control. 
 Abou Neel et al. [54, 55] prepared bulk quaternary glasses 75 
containing TiO2 by conventional melt quenching methods.  
The aim was to test the hypothesis that the combination of 
Ti4+ and Ca2+ ions would further improve the biological 
response of phosphate glasses. The glass compositions studied 
were (P2O5)50(CaO)30(Na2O)20-x(TiO)x, where x = 1, 3 80 
and 5.  MG63 cell proliferation, gene expression, and 
bioactivity were the focus of this study.  Cell proliferation and 
gene expression (Core binding protein factor alpha 1 (Cbfa1), 
alkaline phosphatase (ALP), Collagen type I alpha subunit I 
(COLIAI), and Osteonectin (Sparc)) were reproducibly 85 
enhanced on the surfaces of the Ti4+containing glasses, 
particularly those with 3 and 5 mol% TiO2. The authors 
suggested that this enhancement may be associated with the 
lower degradation of these compositions which help maintain 
pH at a level favoured by osteoblasts.  It was also suggested 90 
that the release of Ti4+ ions may have a beneficial effect on 
bioactivity.  
 Of the three compositions of Ti-doped phosphate based 
glasses investigated, the 5 mol% TiO2 glass induced the most 
favourable cellular response [54].  As a follow-up study, Abou 95 
Neel et al. [56] replaced some of the CaO with in this glass 
with ZnO (1, 3 and 5 mol%) in an attempt to further improve 
the biological properties.  This work concentrated of the effect 
of ZnO additions on the thermal properties, degradation, ion 
release, surface and biological properties.  The results showed 100 
that the addition of ZnO was effective in controlling the bulk, 
and surface properties of the glass.  Glasses containing both 
TiO2 and ZnO demonstrated similar high viability of MG63 
cells up to 7 days to both the 5 mol% TiO2 parent glass with 
and the positive control, Thermanox®.  This cell proliferation 105 
was correlated with the release of beneficial Ca2+, P, Ti4+ 
and Zn2+ ions at suitable level coupled with an increase in 
surface hydrophilicity.  The hydrophilicity is thought to be 
associated with enhanced protein adsorption and adhesion of 
anchorage dependant cells such as osteoblast, fibroblast and 110 
endothelial cells on the surface of biomaterials [57]. 
4.2.3. Antimicrobial Delivery Devices 
Phosphate glasses offer potential alternatives to the current 
methods available for the treatment of infections since they 
can be used as localised antibacterial delivery systems via the  115 
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Figure 3: AFM image of silver free glass surface coated with 
S. aureus biofilm. 
inclusion of ions known for their antibacterial effects such as 
copper, silver, and gallium.  Such materials could therefore be 15 
placed at a site of infection, with the aim of releasing 
antibacterial ions as the glass degrades, which may be useful 
in wound healing applications. Their use could be extended to 
the prevention of implant or biomaterial related infections, 
which are one of the main causes of revision surgery, and to 20 
augment or replace the current prophylaxis of systemically 
administered antibiotics [58]. 
 Antimicrobial glass systems incorporating either Cu2+ or 
Ag+ ions were successfully prepared by Mulligan et al. [59, 
60] for potential applications in the treatment of oral 25 
infections.  The aim was to develop glass devices that could 
be placed at the site of an infection such as in a periodontal 
pocket to treat the infection with the antimicrobial ions 
released as the glass degrades.  Both reports focused on glass 
systems with a fixed P2O5 concentration of 45 mol %, and 30 
concentrations of the antibacterial ions, Cu2+ or Ag+, of 0, 1, 
5, 10 and 15 mol %.  For each system, the calcium oxide to 
sodium oxide (CaO/Na2O) ratio was varied to give the same 
degradation rate over all compositions.  Consequently, the 
overall effect on bacteria was due to the presence or absence 35 
of antibacterial ions and their concentrations. The effect of 
both glass systems on the viability of a Streptococcus Sanguis 
biofilm using constant depth film fermenter (CDFF) was 
evaluated in a simulated oral environment using the glass 
sample containing no antimicrobial and HA (hydroxyapatite) 40 
as controls.  The results demonstrated that after 24 h, there 
was a significant reduction in viable counts of bacteria 
compared to the controls, which was attributed to the release 
of antimicrobial ions.  This reduction was correlated with the 
concentration of antimicrobial ions in the glass.  Despite 45 
recovery of the bacterial counts after 48 h, they were 
significantly lower than those of the controls and remained 
relatively constant between 48 h and eight days.  Two possible 
reasons were proposed for this recovery: firstly, the formation 
of a sacrificial layer of dead bacterial cells that acts as a 50 
barrier against further penetration of the antimicrobial ions 
into the biofilm; secondly, the differentiation of bacteria into 
another phenotype that was resistant. The results also showed 
that Ag+ ions display more potent antimicrobial activity than 
to Cu2+ ions. 55 
 Further work on antimicrobial phosphate glasses was 
carried out by Ahmed et al. [61] who investigated glasses with 
a relatively higher phosphate content.  The compositions  
Figure 4: A cross- sectional view of the S. aureus biofilm on 
20% silver doped PBGs. Viable (green) and non-viable (red) 60 
bacteria (62). 
studied were (P2O5)50(CaO)30(Na2O)20-x(Ag2O)x where x = 
0-15.  Disc diffusion assay was used to screen the 
antibacterial activity of these glasses against various micro-
organisms including Staphylococcus aureus [Figure 3], 65 
Escherichia coli, Bacillus cereus, Pseudomonas aeruginosa, 
methicilline resistant Staphylococcus aureus, and Candida 
albicans.  The results showed that the phosphate glasses 
containing 3 and 5 mol% Ag2O were more effective than the 
remaining compositions in the inhibition of bacterial growth. 70 
Overall it was concluded that the glass with 3 mol% Ag2O 
was of optimal composition to mount a potent antibacterial 
effect against the test micro-organisms since it was 
bactericidal against Staphylococcus aureus, Escherichia coli,  
and significantly reduced the growth of Candida albicans.  75 
These findings were correlated with the excellent long term 
release of Ag ions from that composition into the surrounding 
medium. 
 Further study of silver containing phosphate glasses (10, 15 
and 20 mol%) was performed by Valappil et al. [62] who 80 
tested their effect on the formation of the highly resistant S. 
aureus biofilms.  Silver ions were found to reduce the growth 
of S. aureus biofilms.  Variations in bactericidal activity were 
correlated with glass degradation rates which varied between 
0.42 and1.22 µg.mm-2. h-1 depending on composition. Due to 85 
the antibacterial action of the Ag+ ions, a dead layer, 
approximately 20µm thick, of non-viable bacterial cells was 
formed on the glass surface [Figure 4]; this layer was covered 
by a top layer of viable cells.  The antibacterial effect of these 
glasses was attributed to the silver  ions being present in the 90 
most potent +1 oxidation state; confirmation of this was 
provided by Ag K-edge XANES (X-ray absorption near-edge 
structure) measurements.   
 As well as silver and copper, gallium was also investigated 
as a dopant for phosphate glasses because of its antibacterial 95 
activity [63]. Novel quaternary gallium-doped phosphate 
based glasses ((P2O5)45(CaO)16(Na2O)39-x(Ga2O3)x where x 
= 1, 3 and 5) were synthesized, and their bactericidal activities 
tested against both Gram negative (Escherichia coli and 
Pseudomonas aeruginosa) and Gram positive (Staphylococcus 100 
aureus, methicillin-resistant Staphylococcus aureus, and 
Clostridium difficile) bacteria.  The report confirmed that the 
controlled delivery of Ga3+ ions from the glass containing 1 
mol% Ga2O3 was sufficient to mount a potent bactericidal 
effect and demonstrated the potential of these glasses as a new 105 
therapeutic agent for pathogenic bacteria including the super 
bugs MRSA and C. difficile. 
5. Melt Quenched Phosphate Based Glass Fibres 
Glass fibres have potential applications in the engineering of 
soft tissues such as muscle and ligament due to a combination 110 
of suitable chemistry and morphology which can mimic the 
fibrous nature of these tissues [10].  It has been suggested that  
 (b) (a) 
10 m 
10 m 10 m 
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Figure 5: Phosphate glass fibres drawn with increasing drum 
speeds, which results in decreasing fibre diameter; (a) 35 5, 
(b) 25 3, (c) 16 2, and 11  1 m. 
the glass fibres can act as a template with muscle cells 5 
growing along their long axis and forming myotubes; in 
particular, the three dimensional mesh arrangements have 
proven to be the best configuration for supporting cell 
attachment and proliferation [10, 64]. Glass fibre scaffolds 
with open mesh morphology allow for the diffusion of 10 
nutrient and waste products in and out of the construct, and 
permit the ingrowth of vasculatures and hence the tissue. They 
also provide the necessary structural support without 
compromising porosity [65-67].  Recently, it has been 
suggested that glass fibres could also act as a nerve conduit, 15 
since they can provide a guide for cell orientation, 
proliferation and growth [68, 69]. 
 Phosphate glass fibres are conventionally fabricated by 
drawing from a high temperature melt.  Typically fragments 
of the starting glass are remelted and fibres drawn from the 20 
melt onto a rotating collecting drum [66, 70].  Adjustment of 
the melt temperature is necessary to obtain a suitable viscosity 
for fibre drawing, since it is not feasible glasses with low melt 
viscosities to be drawn into fibres [10].  Additionally, the melt 
temperature should be above the glass crystallisation 25 
temperature; otherwise, fibre drawing becomes difficult [71] 
or the bioactivity of the glasses is reduced [72]. 
 During the drawing process, the fibre diameter can easily 
be controlled by adjusting the drum speed:  higher drum speed 
results in smaller fibre diameter as shown in Figure 5.  From a 30 
biological standpoint, it has been reported that the fibre 
diameter has an effect on cell orientation [68].  It was found 
that as long as the fibre diameter is comparable to the size of 
the cell body, the cells will orientate along the long axis of 
fibre rather than around its circumference.  Cells tend to wrap 35 
around the smaller diameter fibres, but in presence of less 
curvature, they can grow either perpendicular or parallel to 
the long axis.  In such case, the fibres act as a contact guide, 
i.e. guide the cell growth; this is most useful for nerve 
regeneration since neuronal cells can be guided from both 40 
ends of the injured nerve in the right direction. 
Fibre spacing (within a mess construct) can also be adjusted 
by changing the speed of the rotating drum.  As previously 
mentioned, the inter-fibre spacing has an effect of the cell 
proliferation with the number of cells increasing as this 45 
spacing decreases [69].  A small fibre spacing makes it easy 
for cells to cross the gap between these fibres which reduces 
cell compaction of and prolongs proliferation.  Moreover, a 
small inter-fibre spacing also increases the surface area for 
cells to attach and then proliferate. 50 
One of the milestones in tissue engineering has been the 
development of 3D scaffolds that guide cells to form 
functional tissue.  Tissue-engineered constructs that contain a 
controlled spatial distribution of cells and growth factors, as  
Figure 6: MPCs muscle cells (a) attached on iron phosphate 55 
glass fibres (BrdU staining was used to test the ability of 
attached MPCs to undergo replication.), and (b) fused and 
form multinucleate myotubes [Desmin, a cytoplasmic marker 
of all skeletal muscle cells, stained green, while Myogenin, a 
nuclear marker of differentiation, stained, and the nuclei 60 
stained blue] [10].  
Figure 7: SEM images showing the tubular structures 
formed from glass fibres after 18 months of degradation; 
(a) 3 and (b) 5 mol% Fe2O3
 containing glass fibres 
respectively [75].  65 
well as engineered scaffold materials with a well-defined 
microstructure, can now be fabricated [73].  Laying out 
phosphate glass fibres into two or three dimensional scaffolds 
has potential in this regard since such constructs have been 
shown to support cell attachment and proliferation [64]. 70 
5.1. Fibres for Potential Soft Tissue Engineering Applications 
A recent study of a 3D Phosphate glass fibre construct made 
from fibres with a composition of 
(P2O5)62.9(Al2O3)21.9(ZnO)15.2 demonstrated that it could 
support the proliferation and differentiation of human 75 
masseter muscle-derived cell cultures [64].  Parameters such 
as cell density, glass fibre configuration, growth factors and 
extracellular components were shown to be key factors in 
determining how well these glass fibres performed as an 
experimental scaffold material for engineered muscle tissue 80 
[64]. 
 Phosphate glass fibres containing 5-22.5 wt % Fe2O3 have 
been used as reinforcing agents in the development of 
bioabsorbable composites designed for orthopedic 
applications. A cortical plug method was used to test the 85 
biocompatibility of these glasses; the results showed that no 
inflammation was observed over periods of up to five weeks 
[74]. 
 Ahmed et al.  [10] prepared and characterised iron 
containing glass fibres with different of composition 90 
(P2O5)50(CaO)30(Na2O)20-x(Fe2O3)x where x = 1-5. A 
dramatic improvement in immortal muscle precursor cell line 
attachment was observed for fibres with 4 and 5 mol % Fe2O3.  
The high cell density achieved is illustrated in Figure 6 [10].  
Figure 8: SEM of a cross section through the phosphate 95 
 glass fibres-collagen scaffold showing (a) a cluster of 
channels left in the matrix as the fibres degrades, and (b) 
close up of a typical channel [76]. 
In another study, it was that fibres containing 3 mol % Fe2O3 
are compatible with both primary human osteoblasts and 5 
fibroblasts, supporting a clear proliferation pattern, and 
permitting an even growth morphology [50]. 
 Furthermore, Fe2O3 doped phosphate glass fibres have an 
intriguing ability of to form capillary-like channels as they 
degrade in aqueous media.  Figure 7 shows images of these 10 
tubes viewed under an electron microscope.  The degradation 
process which these glass fibres undergo is a combination of 
surface hydration and internal hydrolysis.  Initially, the 
hydration of the outer surface of the fibres forms a protective 
barrier against degradation.  Over longer periods, bulk  15 
degradation takes place by hydrolysis of the long Q2 chains 
into shorter phosphate chains with Q1 and Q0 units dominating 
the structure of the resultant channels as evidenced from both 
FTIR and Raman spectroscopy [75].  
 Further to the previous findings, studies incorporating  20 
phosphate glass fibres containing 3 mol % Fe2O3 have also 
been used as templates for the in situ formation of uni-
directionally aligned channels in 3D dense collagen scaffolds 
[76].  Assessment of diffusion through these scaffolds was 
made by recording the movement of micro-bubble agents 25 
through the construct using ultrasound and SEM imaging.  
The free movement of the coated micro-bubble agents 
confirmed that the channels were continuous in nature and 30-
40 m in diameter (approximately the same fibre diameter) as 
shown in Figure 8.  Moreover, this construct maintained 30 
excellent viability of human oral fibroblasts after 24 hours in 
culture, and the cells showed tightly packed spindle shaped 
appearance forming a three dimensional network; spreading 
over both the collagen matrix and the glass fibres with no 
preference for either of them. 35 
 Phosphate glass fibres with varying amounts of copper 
oxide, 0, 1, 5 and 10 mol% CuO, were produced for potential 
use in wound healing applications.  The effect of two fibre 
diameters on short term (3 hours) attachment and killing 
against Staphylococcus epidermidis were investigated, and 40 
related to their rate of dissolution in deionised water and 
copper ion release.  The results showed that there was a 
significant decrease in the rate of degradation both with 
increasing CuO content and increasing in fibre diameter.  
Over six hours, the amount of copper ions released increased 45 
with both increasing CuO content, and decreasing fibre 
diameter (i.e. increasing surface area to volume ratio).  A 
decrease in the number of viable Staphylococci was observed 
both attached to the CuO containing fibres and in the 
surrounding environment [11]. 50 
6. Low Temperature Sol-gel Synthesis of 
Phosphate Based Glasses 
6.1 Introduction to Sol-Gel Methods 
The sol-gel process is a low temperature wet-chemical 
technique for the fabrication of oxide materials.  The process 55 
starts with a chemical solution that reacts to produce colloidal 
particles; this solution is known as the sol.  Typical precursors 
are inorganic alkoxides and metal chlorides, which undergo 
hydrolysis and polycondensation reactions to form a colloid.  
The sol evolves via further condensation reactions towards the 60 
formation of an inorganic network containing a liquid phase; 
this is known as the gel. Growth of an inorganic network 
occurs via the formation of M-O-M and M-OH-M bridges 
(where M is an electropositive element, typically Si, Ti, Al or 
Zr) which generates polymeric species throughout the solvent 65 
medium.  A drying step serves to remove the liquid phase 
from the gel thus forming a porous material.  Thermal 
treatment (often referred to as calcination) can be used to 
promote further polycondensation, leading to consolidation 
and densification of the material‟s structure.  One of the main 70 
advantages of the sol-gel process is versatility: the precursor 
sol can be either deposited on a substrate to form a film (e.g. 
by dip-coating or spin-coating), cast into a suitable container 
with the desired shape (e.g. to obtain a monolithic ceramics, 
glasses, fibers, membranes, aerogels), or used to synthesize 75 
ultra-fine powders (e.g. microspheres, nanospheres) [77, 78]. 
 The low temperature of the sol-gel process is generally 
below the crystallisation temperature of oxide materials which 
allows for the production or novel glasses and amorphous 
materials.  This and the availability of suitable precursors has 80 
led to the publication of over 5000 papers concerning sol-gel 
derived silica based materials over the last 25 years.  Many 
for these papers concern biomaterials and are a direct result of 
the discovery that silicate based bioactive glasses can be 
prepared by sol-gel methods [79].  The great potential of sol-85 
gel chemistry in this regard is that the low temperature nature 
of the synthesis permits the inclusion of biologically active 
molecules that could not survive the high temperatures 
necessary in the preparation of glass biomaterials by melt 
quenching methods. To date, proteins [80, 81], antibiotics [82] 90 
and chemotherapy agents [83, 84] have all been successfully 
incorporated into silica based glass biomaterials using sol-gel 
chemistry: the porous nature of these materials allows 
controlled release of the biologically active molecules over 
long periods of time, thus offering the potential of sustained 95 
in-situ therapy.  Furthermore, biocompatible polymers can 
also be included in the synthesis to produce materials with 
improved mechanical properties for use as tissue engineering 
scaffolds [85]. 
 In contrast to the volume of work on silica based sol-gel 100 
biomaterials, there is much less on phosphate based 
biomaterials prepared by the same methods. Of the studies 
published so far, most concern the sol-gel preparation of 
powders or coatings of hydroxyapatite [86-89] or other 
crystalline calcium phosphates [90-92].  The examples 105 
focused on bioactive glasses are almost exclusively studies of 
phosphosilcates with a high silica content [93, 94]. 
 6.2 Sol-Gel Synthesis of Phosphate Based Glasses 
The reason for the dearth of literature examples of the sol-gel 
preparation of phosphate based glasses is that it is 
significantly more demanding than the preparation of silicate 
glasses by the same methods.  The problem is finding the right 5 
phosphorus precursor: the hydrolysis of alkyl phosphates is 
very slow under sol-gel conditions and phosphate anions (e.g. 
PO4
3-) tend to form precipitates rather than network structures 
based upon P O P bonding [95]. As a solution to this 
problem, Livage et al. [95] suggested using PO(OH)3-x(OR)x 10 
(where R = alkyl group) precursors, obtained via the 
dissolution of P2O5 in alcohols.  Using this method, they 
prepared some Ti-phosphates from clear sols with a P/Ti ratio 
of 1.  Lee et al. also successfully reacted PO(OH)3-x(OR)x (R 
= ethyl or butyl, x = 1 or 2) with alkoxides of lithium, sodium, 15 
silicon, potassium and zinc to form a multicomponent glass 
[96]. The suitability of PO(OH)3-x(OR)x compounds as sol-gel 
precursors was further illustrated by a study by Noda et al. 
[97].  This study focused on the effect of phosphorus sources 
on the synthesis of KTiOPO4 thin films by the sol-gel 20 
method. Triethylphosphate (OP(OEt)3), phosphorus pentoxide 
(P2O5),di-n-butylphosphate ((nBuO)2PO(OH)), 
ethylphosphonate ((EtO)P(OH)2), methylphosphonate 
((MeO)P(OH)2), and trimethylphosphonate ((P(OMe)3) were 
all tested as starting phosphorus compounds. The results 25 
indicated that phosphorus compounds with hydroxy groups 
reacted with the Ti alkoxides to form Ti-O-P bonds, which 
prevented the undesirable evaporation of phosphorus 
compounds during heat treatment. 
 Some of the less favourable precursors phosphate have also 30 
successfully been employed in the synthesis of amorphous 
phosphate based materials.  Makino et al. [98] prepared 
Mg0.5Ti2(PO4)3 gels from Mg(CH3COO)2·4H2O and 
NH4H2PO4 in aqueous solution and 
C4H9O[Ti(OC4H9)2O]4C4H9 in ethanol.  Their samples 35 
remained amorphous even after heating to 500 oC.  Tang et al. 
[99] prepared TiO2-P2O5 glasses with potential photonics 
application from the reaction of triethylphosphate with 
titanium isopropoxide. 
`Over the last five years, nearly all the work on sol-gel 40 
prepared phosphate based glasses has involved one of two 
synthetic routes, which have now emerged as almost the 
standard procedures.  The first of these is the, previously 
described, reaction of a 1:1 molar mixture of OP(OH)2(OR) 
and OP(OH)(OR)2 with reactive metal alkoxides and the 45 
second is the reaction of aluminium lactate with an aqueous 
phosphate solution.  The former method has recently been 
used to prepare (TiO2)0.5(P2O5)0.5 gels and glasses which 
have potential applications in humidity sensors and photonics, 
respectively [100].  The latter method has been successfully 50 
used to prepare clear, monolithic Al2O3-P2O5 and Na2O-
Al2O3-P2O5 gels by reacting aluminium lactate with 
phosphoric acid solution or sodium polyphosphate solution, 
respectively [101, 102].  Such glasses are useful in a number 
of applications including as catalysts and catalyst supports, 55 
laser devices, solid-state batteries, and hermetic seals to 
materials with high thermal expansion coefficients.  This sol-
gel synthesis has recently been used to extend the glass 
forming region of the B2O3-Al2O3-P2O5 system [103] and to 
prepare aluminium fluoride phosphate glasses [104]. 60 
6.3 Phosphate Based Sol-Gel Biomaterials 
The first sol-gel phosphate based glasses specifically aimed at 
biomedical applications were synthesized by Carta et al. 
[105].  CaO-Na2O-P2O5 glasses were prepared by reacting 
mono- and di-substituted ethylphosphate with alkoxides of the 65 
calcium and sodium in ethylene glycol.  This method, 
however, has significant disadvantages in that relatively high 
temperatures are required to remove the ethylene glycol 
solvent from the gels and the resultant glasses do not exhibit 
significant porosity, possibly as a result of the necessary heat 70 
treatment.  Recently, a new sol-gel route to phosphate-based 
materials that produces glassy gels at lower temperatures than 
previously reported has been developed [106].  Samples were 
prepared by the reaction of a 1:1 molar mixture of mono- and 
di-substituted n-butylphosphate with sodium methoxide and 75 
calcium methoxyethoxide in an alcohol solvent mix.  
Sructural characterisation of the samples was carried out using 
a combination of thermal analysis, FTIR, 31P solid state NMR 
and high-energy XRD.  The results demonstrated that 
hydrated (CaO)0.3(Na2O)0.2(P2O5)0.5 samples with structures 80 
comparable to their melt-quenched counterparts could be 
prepared with a maximum processing temperature in the range 
200-250 °C.  The main structural difference between the melt-
quenched and the sol-gel samples was that the latter were 
partially hydrated.  The results also suggest that the reactive 85 
nature of the sodium methoxide and calcium methoxyethoxide 
helps promote P-O-P linkages during the sol-gel reation.  
Furthermore, it was shown that this method can be used to 
produce porous foams, which have potential applications as 
tissue engineering scaffolds. 90 
 In a related study, CaO-TiO2-P2O5 glasses for potential 
biomedical applications were prepared by a similar sol-gel 
method [107].  The structure of samples were characterised 
using high enrgy X-ray diffraction [107] and Ti K-edge 
XANES [108]. 95 
 The recent developments described above encourage 
further exploitation of sol-gel chemistry in the preparation of 
phosphate based biomaterials.  In particular, it should now be 
possible to include biologically active molecules that are not 
stable to high temperature, such as proteins, antibiotic and 100 
other drugs, in the synthesis.  Bioactive polymers could also 
be included to improve the mechanical properties of the 
resultant materials, thus providing materials with improved 
properties for use in tissue engineering constructs.  Finally, 
there exists the potential to coat biomedical devices with a 105 
sol-gel derived antimicrobial coating via the inclusion of 
biocidal metal ions such as Ag+ and Ga3+. 
7. Outlook for Phosphate Based Glasses 
Zinc phosphate glasses could be potentially be used for the 
treatment of chronic inflammatory diseases such as Crohn‟s 110 
disease and rheumatoid arthritis, which are both characterised 
by decreased Zn2+ levels in the blood. 
 Phosphate glass fibres could be used as a vehicle for cell 
delivery to inaccessible areas – e.g. for the delivery of 
 periodontal ligament cells in the treatment of advanced 
periodontitis. 
 Phosphate based glass fibres with antimicrobial properties 
could be prepared in a mesh form for use as a wound dressing 
for the treatment of sever burns, leg ulcers, pressure sores, 5 
and infected surgical wounds, providing both protection 
against the ingress of micro-organisms and releasing 
antimicrobial ions (e.g. Cu2+, Ag+ and Ga3+) as they dissolve 
to help combat infection.  Such meshes would be used on a 
temporary bases with the highly degradable nature of the 10 
fibres is benefiting the release of antimicrobial agents.  These 
fibrescould also be incorporated into bone cements used in the 
fixation of orthopaedic devices such as replacement hips.  The 
antibacterial ions released from the bone cement into the 
tissue surrounding the replacement device could help control 15 
the number of bacteria left in the operative wound. 
 The ability of phosphate glass fibres to form microtubes as 
they degrade formation through the degradation of these could 
potentially be applied to a number of areas including drug 
delivery and cell transportation, e.g. to act as a conduit during 20 
nerve healing by transporting nerve cells.  Moreover, they 
could be used in combination with either natural or synthetic 
polymers to help the in-growth of vascularisation and the 
diffusion of nutrient and waste through 3D scaffolds for soft 
and hard tissue engineering: e.g., the engineering of muscle, 25 
ligament, tendon, or bone.  It would also be possible to 
fabricate one construct containing fibres with different 
degradation rates so that the rapidly degrading fibres could 
provide in situ channels for the rapid growth of blood vessels, 
and the more stable fibres could aid the alignment of cells to 30 
form the proposed tissue.  
 Recent developments in phosphate based sol-gel chemistry, 
now mean that biologically active molecules that are not 
stable to high temperature, such as proteins, antibiotic and 
other drugs, can be included in the synthesis.  The resultant 35 
materials have potential to be used in devices to target the 
delivery of such molecules in the human body and provide 
controlled, sustained in-situ therapy. Bioactive polymers 
could also be included in the synthesis to produce materials 
with improved mechanical properties for use in tissue 40 
engineering constructs.  Finally, there exists the potential to 
coat biomedical devices with a sol-gel derived antimicrobial 
coating via the inclusion of biocidal metal ions such as Ag+ 
and Ga3+. 
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